Month: August 2014

Older people are at no greater risk of harmful complications from taking the newest generation of blood-thinning drugs in place of the older standard, warfarin (Coumadin).

Early-diagnosis tests for Alzheimer’s disease are in the research stage but are not reliable. Genetic testing may be considered under certain circumstances, but without a good treatment for the disease, testing offers little medical benefit.

Remaining mentally active later in life may still delay aging-related loss of memory and thinking skills, even in those with less lifetime intellectual stimulation from their education and occupation.